Symbol Lookup

Thursday June 30, 2016 6:17 AM ET. Data delayed 15 minutes.
2.91
0.00 (0.00%)
Bid/Lots
0.00/0
Ask/Lots
3.83/1
Open/Prev Close
0.00/2.91
Day Range
-----
52-Week Range
2.62-26.34
Vol/Avg Daily Vol
0.0/58.3K
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
  • NASDAQ
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
CombiMatrix Study Results Show Superior Value of Microarray Analysis for Recurrent Pregnancy Loss Testing
7:44AM ET on Friday Jun 24, 2016 by MT Newswires
07:44 AM EDT, 06/24/2016 (MT Newswires) -- CombiMatrix (CBMX), a molecular diagnostics company specializing in DNA-based reproductive health and pediatric testing services, unveiled Friday new data from a retrospective study demonstrating a high ...
CombiMatrix Study Published in Genetics in Medicine Establishes the Superior Diagnostic Value of Microarray Analysis over Karyotyping for Recurrent Pregnancy Loss Testing
6:00AM ET on Friday Jun 24, 2016 by GlobeNewswire

CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based reproductive health and pediatric testing services, announces the publication of data from a large retrospective study demonstrating a high success...

CombiMatrix To Begin in Mid-June Accepting Genetic Screening Samples Using Next-Generation Sequencing
3:21PM ET on Wednesday Jun 01, 2016 by MT Newswires
03:21 PM EDT, 06/01/2016 (MT Newswires) -- CombiMatrix (CBMX) rose in Wednesday's afternoon trade after the provider of molecular diagnostic solutions said it will begin accepting samples for pre-implantation genetic screening (PGS) by next gener...
CombiMatrix Launches Next Generation Sequencing for Pre-Implementation Genetic Screening
6:00AM ET on Wednesday Jun 01, 2016 by GlobeNewswire

CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for pre-implantation genetic diagnostics and screening, miscarriage analysis, prenatal and pediatric diagnostics, announces that i...

Company Information

CombiMatrix Corporation is a provider of molecular diagnostic solutions. The Company specializes in pre-implantation genetic screening, miscarriage analysis, prenatal diagnosis and pediatric developmental disorders, offering deoxyribonucleic acid-based testing for the detection of genetic abnormalities, which cannot be identified through traditional methodologies. It performs genetic testing utilizing a range of cytogenomic techniques, including chromosomal microarray analysis, fluorescence in situ hybridization and karyotyping. Its prenatal and postnatal microarray focuses on diagnosing genomic syndromes associated with intellectual disability, developmental delays, congenital anomalies, dysmorphic features and autism spectrum disorders. It develops and markets its molecular testing services in approximately four markets, such as in vitro fertilization (IVF), miscarriage analysis (products of conception analysis), prenatal genetics and postnatal developmental disorders.

CONTACT INFORMATION

Headquarters310 Goddard Ste 150
IRVINE, CA, United States 92618-4617
Phone949-753-0624
Fax949-753-1504

EXECUTIVE OFFICERS

Chairman of the Board, President, Chief Executive OfficerRobert Jessup
DirectorMark McDonough
Chief Financial Officer, Treasurer, SecretaryScott Burell
Independent DirectorScott Gottlieb
Independent DirectorRobert Hoffman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  •  
  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$3.9MBeta0.38
Revenue (TTM)$10.7MEPS$-9.55
Shares Out.1.3MBook Value$6.93
Dividend Yield0.00%P/E--
Annual Dividend Rate0.00 USDPrice/Sales (TTM)0.4
Ex-Div Date1/1/01P/Cash Flow (TTM)--
Pay Date1/1/01Operating Margin-58.40%

*GAAP = prior to non-GAAP analyst adjusted earnings.

(Non-GAAP)*

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample